Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.

NCT00759382 is registered in ClinicalTrials.gov with European Lung Cancer Working Party as lead sponsor.

NCT NCT00759382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00759382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.
Lead sponsor
European Lung Cancer Working Party
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2008
Completion date
January 31, 2022
Enrollment
340 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung carcinoma